Combination therapies for MPNSTs targeting RABL6A-RB1 signaling

Precision medicine relies on a detailed molecular understanding of disease pathogenesis. Here, we consider urgently needed therapeutic options for malignant peripheral nerve sheath tumors (MPNSTs) based on emerging insights into druggable pathway alterations found to drive this deadly cancer. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohlmeyer, Jordan L., Gordon, David J., Tanas, Munir R., Dodd, Rebecca D., Monga, Varun, Darbro, Benjamin W., Quelle, Dawn E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800773/
https://www.ncbi.nlm.nih.gov/pubmed/33456709
http://dx.doi.org/10.18632/oncotarget.27862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800773/
https://www.ncbi.nlm.nih.gov/pubmed/33456709
http://dx.doi.org/10.18632/oncotarget.27862

Ejemplares similares